Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **cortico-striato-thalamo-cortical pathway** is a major neural circuit in the brain that connects regions of the cerebral cortex with the striatum, thalamus, and back to the cortex. It consists of several parallel loops that are functionally segregated—such as motor, oculomotor, dorsolateral prefrontal, orbitofrontal, and anterior cingulate circuits—each supporting distinct aspects of behavior including movement control, cognitive flexibility, reward evaluation, affect regulation, and salience processing. Dysfunction within these loops has been implicated in various neurological and psychiatric conditions including Parkinson’s disease, Huntington’s disease, obsessive-compulsive disorder (OCD), Tourette syndrome, major depressive disorder (MDD), dystonia and substance use disorders. The CSTC pathways are not molecular targets themselves but rather anatomical/functional circuits composed of multiple neuron types utilizing neurotransmitters like dopamine and glutamate. Therapeutic interventions often aim to modulate activity within these circuits using pharmacological agents or neuromodulation techniques rather than targeting a specific molecule or receptor. **Note:** This entry is marked "is_incorrect" because it refers to an anatomical/functional neural network rather than a discrete molecular target such as a receptor or enzyme.
Not applicable as a direct molecular target; neuromodulation therapies such as deep brain stimulation (DBS), repetitive transcranial magnetic stimulation (rTMS), and transcranial direct current stimulation (tDCS) can alter activity in this circuitry for therapeutic purposes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cortico-striato-thalamo-cortical pathway (CSTC pathway).